Recently, we have demonstrated that the Na+⁄H+ exchanger regulatory factor 1 (NHERF1), an adaptor protein for membrane macromolecular complexes, is a potential candidate of clinical relevance for human breast cancer [17-19]. Here, NHERF1 is linked to breast carcinoma.